2015至2019年芬兰某医院与蚕豆产品相关的单核细胞增生李斯特菌疫情
2019年4月芬兰某医院两名患者诊断为李斯特菌病,研究定义为实验室确诊单核细胞增生李斯特菌(Lm)血清群IIa序列型37(ST 37)病例。2015至2019年芬兰传染病登记处共报告6例Lm ST 37病例,通过患者访谈和医院菜单追溯可疑食品,2021和2022年从一款含蚕豆的即食植物基食品样本中检出相似Lm ST 37。制造商和地方食品监管机构检查表明,食品在巴氏杀菌后受到Lm污染。
要点
- 2015至2019年芬兰传染病登记处共报告6例Lm ST 37病例。
- 2021和2022年从含蚕豆的即食植物基食品样本中检出相似Lm ST 37。
- 检查表明食品在巴氏杀菌后受到Lm污染。
核心结论
- 调查强调生产植物基食品的公司应接受与生产动物源食品的公司类似的管控。
- 医院菜单可作为不依赖患者回忆的有用信息来源。
研究设计与样本
- 描述性研究,定义病例为实验室确诊Lm血清群IIa序列型37(ST 37)的人员。
- 2015至2019年芬兰传染病登记处共报告6例Lm ST 37病例。
主要发现
- 2019年4月芬兰某医院两名患者诊断为李斯特菌病。
- 2015至2019年芬兰传染病登记处共报告6例Lm ST 37病例。
- 2021和2022年从含蚕豆的即食植物基食品样本中检出相似Lm ST 37。
- 制造商和地方食品监管机构检查表明食品在巴氏杀菌后受到Lm污染。
临床怎么用
- 作者认为医院菜单可作为不依赖患者回忆的有用信息来源。
- 作者认为生产植物基食品的公司应接受与生产动物源食品的公司类似的管控。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Listeria monocytogenes (Lm) is a bacterium widely distributed in the environment. Listeriosis is a severe disease associated with high hospitalisation and mortality rates. In April 2019, listeriosis was diagnosed in two hospital patients in Finland. We conducted a descriptive study to identify the source of the infection and defined a case as a person with a laboratory-confirmed Lm serogroup IIa sequence type (ST) 37. Six cases with Lm ST 37 were notified to the Finnish Infectious Diseases Registry between 2015 and 2019. Patient interviews and hospital menus were used to target traceback investigation of the implicated foods. In 2021 and 2022, similar Lm ST 37 was detected from samples of a ready-to-eat plant-based food product including fava beans. Inspections by the manufacturer and the local food control authority indicated that the food products were contaminated with Lm after pasteurisation. Our investigation highlights the importance that companies producing plant-based food are subject to similar controls as those producing food of animal origin. Hospital menus can be a useful source of information that is not dependent on patient recall.
引用
- Otte Im Kampe E, Salmenlinna S, Åberg R, et al. Outbreak of Listeria monocytogenes in hospital linked to a fava bean product, Finland, 2015 to 2019. Euro Surveill. 2024. PMID: 38726694. doi:10.2807/1560-7917.ES.2024.29.19.2300488
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。